Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,896 | 52 | 96.5% |
| Education | $68.07 | 2 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $356.46 | 8 | $0 (2021) |
| NeoTract Inc. | $289.17 | 2 | $0 (2020) |
| Astellas Pharma US Inc | $241.97 | 13 | $0 (2019) |
| GENZYME CORPORATION | $147.43 | 2 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $138.63 | 2 | $0 (2018) |
| AbbVie, Inc. | $121.56 | 1 | $0 (2019) |
| Olympus America Inc. | $116.96 | 1 | $0 (2019) |
| Photocure Inc | $64.59 | 1 | $0 (2017) |
| Agiliti Surgical, Inc. | $60.46 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $57.61 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $41.80 | 3 | BOSTON SCIENTIFIC CORPORATION ($25.56) |
| 2020 | $179.84 | 3 | NeoTract Inc. ($141.52) |
| 2019 | $657.75 | 16 | Boston Scientific Corporation ($222.54) |
| 2018 | $596.25 | 14 | NeoTract Inc. ($147.65) |
| 2017 | $488.21 | 18 | Astellas Pharma US Inc ($170.08) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/01/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL MALE SUI (Device) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/01/2021 | 180 Medical, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| 02/27/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $141.52 | General |
| Category: Interventional Urology | ||||||
| 02/11/2020 | Coloplast Corp | SPEEDICATH (Device) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: CONTINENCE | ||||||
| 01/08/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/19/2019 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Oncology | ||||||
| 12/16/2019 | Boston Scientific Corporation | REZUM (Device) | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: PROSTATE HEALTH | ||||||
| 12/05/2019 | Olympus America Inc. | Olympus Cysto-Resection (Device) | Food and Beverage | In-kind items and services | $116.96 | General |
| Category: Urology/Gynecology Products | ||||||
| 10/02/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/06/2019 | Boston Scientific Corporation | AMS (Device) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 07/31/2019 | Amgen Inc. | MVASI (Biological), Neulasta, Vectibix | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Oncology | ||||||
| 07/24/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2019 | Agiliti Surgical, Inc. | — | Food and Beverage | Cash or cash equivalent | $60.46 | General |
| Category: Surgical lasers | ||||||
| 07/10/2019 | Boston Scientific Corporation | AMS (Device) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 06/19/2019 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2019 | Boston Scientific Corporation | AMS (Device) | Food and Beverage | In-kind items and services | $166.99 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 02/19/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $121.56 | General |
| Category: Endocrinology | ||||||
| 02/07/2019 | Boston Scientific Corporation | GENERAL BPH (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: BPH | ||||||
| 01/30/2019 | Spectrum Pharmaceuticals Inc. | Folotyn (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Oncology | ||||||
| 12/12/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.80 | General |
| Category: Oncology | ||||||
| 11/29/2018 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2018 | Egalet US Inc | SPRIX (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Pain Medicine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 484 | 578 | $81,368 | $18,615 |
| 2020 | 12 | 1,028 | 1,378 | $212,417 | $49,908 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 153 | 179 | $48,053 | $10,704 | 22.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 19 | 21 | $14,551 | $3,463 | 23.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 22 | $7,602 | $2,071 | 27.2% |
| 81002 | Urinalysis, manual test | Office | 2021 | 179 | 237 | $2,474 | $824.76 | 33.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $5,425 | $813.93 | 15.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 95 | 103 | $3,263 | $736.89 | 22.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 232 | 339 | $77,890 | $17,934 | 23.0% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 56 | 66 | $42,602 | $10,122 | 23.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 98 | 98 | $32,389 | $7,259 | 22.4% |
| 55700 | Biopsy of prostate gland | Office | 2020 | 26 | 26 | $20,087 | $4,703 | 23.4% |
| 76872 | Ultrasound of rectum | Office | 2020 | 26 | 28 | $12,327 | $3,178 | 25.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 312 | 502 | $5,241 | $1,701 | 32.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 186 | 220 | $7,168 | $1,652 | 23.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 17 | $5,669 | $1,494 | 26.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 29 | 30 | $4,171 | $924.08 | 22.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 11 | $3,669 | $725.60 | 19.8% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 14 | 15 | $1,051 | $175.50 | 16.7% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2020 | 24 | 26 | $152.93 | $39.07 | 25.5% |
About Dr. Scott Slavis, MD
Dr. Scott Slavis, MD is a Urology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700879053.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Slavis, MD has received a total of $1,964 in payments from pharmaceutical and medical device companies, with $41.80 received in 2021. These payments were reported across 54 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($1,896).
As a Medicare-enrolled provider, Slavis has provided services to 1,512 Medicare beneficiaries, totaling 1,956 services with total Medicare billing of $68,523. Data is available for 2 years (2020–2021), covering 18 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Transplant Surgery
- Location Las Vegas, NV
- Active Since 08/23/2005
- Last Updated 03/28/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1700879053
Products in Payments
- UroLift (Device) $289.17
- AMS (Device) $205.88
- JEVTANA (Drug) $147.43
- XIAFLEX (Biological) $138.63
- Lupron Depot (Drug) $121.56
- Olympus Cysto-Resection (Device) $116.96
- Myrbetriq (Drug) $115.08
- LITHOVUE (Device) $108.36
- Cysview (Drug) $64.59
- XTANDI (Drug) $48.10
- PROVENGE (Drug) $43.32
- OPDIVO (Biological) $40.52
- SpaceOAR (Device) $30.45
- BMD-Magic3 Catheter (Device) $29.29
- Kyprolis (Biological) $29.09
- MYRBETRIQ (Drug) $23.79
- IMFINZI (Drug) $21.59
- ZYTIGA (Drug) $21.29
- Folotyn (Drug) $18.69
- EMPLICITI (Biological) $17.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Las Vegas
Vijay Goli, M.d, M.D
Urology — Payments: $322,441
Joel Abbott, D.o, D.O
Urology — Payments: $115,145
Victor Grigoriev, M.d, M.D
Urology — Payments: $75,593
Omid Lesani, M.d, M.D
Urology — Payments: $52,856
Sheldon Freedman, Md, MD
Urology — Payments: $43,617
Michael Verni, M.d, M.D
Urology — Payments: $42,412